R-CHOP regimen: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
mNo edit summary
 
(5 intermediate revisions by 2 users not shown)
Line 9: Line 9:


==Regimen==
==Regimen==
[[Rituximab|{{button|R – Rituximab}}]]
{{chemo|R|Rituximab}}


[[Cyclophosphamide|{{button|C – Cyclophosphamide}}]]
{{chemo|C|Cyclophosphamide}}


[[Doxorubicin|{{button|H – Doxorubicin (Hydroxydaunomycin)}}]]
{{chemo|H|Doxorubicin (Hydroxydaunomycin)}}


[[Vincristine|{{button|O – Vincristine (Oncovin)}}]]
{{chemo|O|Vincristine (Oncovin)}}


[[Prednisone|{{button|P – Prednisone}}]]
{{chemo|P|Prednisone}}


==Indications==
==Indications==
* [[Non-Hodgkin lymphoma]]<ref>{{Cite journal | doi = 10.1056/NEJMoa011795 | issn = 1533-4406 | volume = 346 | issue = 4 | pages = 235–242 | last = Coiffier | first = Bertrand | coauthors = Eric Lepage, Josette Briere, Raoul Herbrecht, Hervé Tilly, Reda Bouabdallah, Pierre Morel, Eric Van Den Neste, Gilles Salles, Philippe Gaulard, Felix Reyes, Pierre Lederlin, Christian Gisselbrecht | title = CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma | journal = The New England Journal of Medicine | date = 2002-01-24 | pmid = 11807147 }}</ref>
* [[Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma, untreated]]<ref>{{Cite journal | doi = 10.1056/NEJMoa011795 | issn = 1533-4406 | volume = 346 | issue = 4 | pages = 235–242 | last = Coiffier | first = Bertrand | coauthors = Eric Lepage, Josette Briere, Raoul Herbrecht, Hervé Tilly, Reda Bouabdallah, Pierre Morel, Eric Van Den Neste, Gilles Salles, Philippe Gaulard, Felix Reyes, Pierre Lederlin, Christian Gisselbrecht | title = CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma | journal = The New England Journal of Medicine | date = 2002-01-24 | pmid = 11807147 }}</ref>
 
* [[Mantle cell lymphoma]]<ref>{{Cite journal | doi = 10.1056/NEJMoa1200920 | issn = 1533-4406 | volume = 367 | issue = 6 | pages = 520–531 | last = Kluin-Nelemans | first = H. C. | coauthors = E. Hoster, O. Hermine, J. Walewski, M. Trneny, C. H. Geisler, S. Stilgenbauer, C. Thieblemont, U. Vehling-Kaiser, J. K. Doorduijn, B. Coiffier, R. Forstpointner, H. Tilly, L. Kanz, P. Feugier, M. Szymczyk, M. Hallek, S. Kremers, G. Lepeu, L. Sanhes, J. M. Zijlstra, R. Bouabdallah, P. J. Lugtenburg, M. Macro, M. Pfreundschuh, V. Procházka, F. Di Raimondo, V. Ribrag, M. Uppenkamp, M. André, W. Klapper, W. Hiddemann, M. Unterhalt, M. H. Dreyling | title = Treatment of older patients with mantle-cell lymphoma | journal = The New England Journal of Medicine | date = 2012-08-09 | pmid = 22873532 }}</ref>
==See also==
* [[CEP regimen]]
* [[CHOEP regimen]]
* [[CHOP regimen]]
* [[COP regimen]]
* [[R-CHOEP regimen]]
* [[R-Maxi-CHOP regimen]]
* [[R-Mega-CHOEP regimen]]


==References==
==References==

Latest revision as of 13:45, 11 March 2015

WikiDoc Resources for R-CHOP regimen

Articles

Most recent articles on R-CHOP regimen

Most cited articles on R-CHOP regimen

Review articles on R-CHOP regimen

Articles on R-CHOP regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on R-CHOP regimen

Images of R-CHOP regimen

Photos of R-CHOP regimen

Podcasts & MP3s on R-CHOP regimen

Videos on R-CHOP regimen

Evidence Based Medicine

Cochrane Collaboration on R-CHOP regimen

Bandolier on R-CHOP regimen

TRIP on R-CHOP regimen

Clinical Trials

Ongoing Trials on R-CHOP regimen at Clinical Trials.gov

Trial results on R-CHOP regimen

Clinical Trials on R-CHOP regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on R-CHOP regimen

NICE Guidance on R-CHOP regimen

NHS PRODIGY Guidance

FDA on R-CHOP regimen

CDC on R-CHOP regimen

Books

Books on R-CHOP regimen

News

R-CHOP regimen in the news

Be alerted to news on R-CHOP regimen

News trends on R-CHOP regimen

Commentary

Blogs on R-CHOP regimen

Definitions

Definitions of R-CHOP regimen

Patient Resources / Community

Patient resources on R-CHOP regimen

Discussion groups on R-CHOP regimen

Patient Handouts on R-CHOP regimen

Directions to Hospitals Treating R-CHOP regimen

Risk calculators and risk factors for R-CHOP regimen

Healthcare Provider Resources

Symptoms of R-CHOP regimen

Causes & Risk Factors for R-CHOP regimen

Diagnostic studies for R-CHOP regimen

Treatment of R-CHOP regimen

Continuing Medical Education (CME)

CME Programs on R-CHOP regimen

International

R-CHOP regimen en Espanol

R-CHOP regimen en Francais

Business

R-CHOP regimen in the Marketplace

Patents on R-CHOP regimen

Experimental / Informatics

List of terms related to R-CHOP regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone regimen

Overview

R-CHOP regimen refers to an immunochemotherapy regimen consisting of rituximab, cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine (Oncovin) and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma.[1][2]

Regimen

RRituximab

CCyclophosphamide

HDoxorubicin (Hydroxydaunomycin)

OVincristine (Oncovin)

PPrednisone

Indications

References

  1. ↑ "NCI Thesaurus".
  2. ↑ "R-CHOP - National Cancer Institute".
  3. ↑ Coiffier, Bertrand (2002-01-24). "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma". The New England Journal of Medicine. 346 (4): 235–242. doi:10.1056/NEJMoa011795. ISSN 1533-4406. PMID 11807147. Unknown parameter |coauthors= ignored (help)
  4. ↑ Kluin-Nelemans, H. C. (2012-08-09). "Treatment of older patients with mantle-cell lymphoma". The New England Journal of Medicine. 367 (6): 520–531. doi:10.1056/NEJMoa1200920. ISSN 1533-4406. PMID 22873532. Unknown parameter |coauthors= ignored (help)
Retrieved from "https://www.wikidoc.org/index.php?title=R-CHOP_regimen&oldid=1077143"